2C-T-2: Difference between revisions

Line 7:

Anecdotal reports tend to characterize 2C-T-2 as a highly dose sensitive psychedelic known for its strong visuals and unpredictably intense body load.

Following the initial positive results found by Shulgin's research group, a more formal study was carried out by psychedelic psychotherapy pioneer by Myron J. Stolaroff who was interested in evaluating the potential use of 2C-T-2 in psychotherapy<ref>Stolaroff, MJ; Wells, C. Preliminary results with new psychoactive agents 2C-T-2 and 2C-T-7. In Jahrbuch für Ethnomedizin und Bewußtseinsforschung (Yearbook of Ethnomedicine and the Study of Consciousness); Rätsch, C; Baker, J, Eds., 1993; Vol. 2, pp 99–117. (MAPS.org) | http://www.maps.org/images/pdf/1993_stolaroff_1.pdf</ref>. Based on the experiences of forty participants in the study who took 2C-T-2, Stolaroff compared the effects favourably to [[MDMA]], describing it as more emotionally opening and permitting a wider exploration of feelings and thoughts. Although presenting a very positive evaluation of the drug, Stolaroff also noted that because it permitted repressed feelings to surface more readily than MDMA, the experience could be uncomfortable for some users.

Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-2, and it has little history of human usage. Many reports also indicate that the physical effects are too severe for those who are not already experienced with [[psychedelics]] or suffer from pre-existing physical conditions as it is known to cause powerful [[nausea]] and general bodily discomfort that may dominate the rest of the experience. It is highly advised to approach this potent, physically unpredictable, and long-lived [[psychedelic]] substance with the proper amount of precaution and [[harm reduction practices]] if choosing to use it.

@@ Line 7: / Line 7: @@
 Anecdotal reports tend to characterize 2C-T-2 as a highly dose sensitive psychedelic known for its strong visuals and unpredictably intense body load.
+Following the initial positive results found by Shulgin's research group, a more formal study was carried out by psychedelic psychotherapy pioneer by Myron J. Stolaroff who was interested in evaluating the potential use of 2C-T-2 in psychotherapy<ref>Stolaroff, MJ; Wells, C. Preliminary results with new psychoactive agents 2C-T-2 and 2C-T-7. In Jahrbuch für Ethnomedizin und Bewußtseinsforschung (Yearbook of Ethnomedicine and the Study of Consciousness); Rätsch, C; Baker, J, Eds., 1993; Vol. 2, pp 99–117. (MAPS.org) | http://www.maps.org/images/pdf/1993_stolaroff_1.pdf</ref>. Based on the experiences of forty participants in the study who took 2C-T-2, Stolaroff compared the effects favourably to [[MDMA]], describing it as more emotionally opening and permitting a wider exploration of feelings and thoughts. Although presenting a very positive evaluation of the drug, Stolaroff also noted that because it permitted repressed feelings to surface more readily than MDMA, the experience could be uncomfortable for some users.
 Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-2, and it has little history of human usage. Many reports also indicate that the physical effects are too severe for those who are not already experienced with [[psychedelics]] or suffer from pre-existing physical conditions as it is known to cause powerful [[nausea]] and general bodily discomfort that may dominate the rest of the experience.  It is highly advised to approach this potent, physically unpredictable, and long-lived [[psychedelic]] substance with the proper amount of precaution and [[harm reduction practices]] if choosing to use it.